# OnCo record paper-preopanc-preoperative-chemoradiotherapy-jco-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-preopanc-preoperative-chemoradiotherapy-jco-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-preopanc-preoperative-chemoradiotherapy-jco-2020" ;
  schema:name "Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial"@en ;
  schema:description "The 2020 primary report of the Dutch PREOPANC trial: giving chemotherapy and radiotherapy before surgery did not significantly lengthen survival overall, but it raised clear-margin resections from 40 to 71 percent and helped the patients whose tumours were borderline operable."@en ;
  schema:url <https://onco.cc/key-papers/paper-preopanc-preoperative-chemoradiotherapy-jco-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.02274>, <https://pubmed.ncbi.nlm.nih.gov/32105518/>, <https://www.onderzoekmetmensen.nl/en/trial/24580> ;
  onco:tag "pancreatic-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.02274> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Versteijne E, Suker M, Groothuis K, et al." ;
  onco:related <https://onco.cc/key-papers/paper-preopanc-neoadjuvant-chemoradiotherapy-long-term-jco-2022/>, <https://onco.cc/key-papers/paper-preopanc-2-neoadjuvant-folfirinox-vs-chemoradiotherapy-lancet-oncol-2025/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/>, <https://onco.cc/cancers/borderline-resectable-pdac/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/surgery/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:institutions <https://onco.cc/institutions/erasmus-mc/>, <https://onco.cc/institutions/amsterdam-umc/> ;
  onco:terms <https://onco.cc/terms/resectability/>, <https://onco.cc/terms/resection-margins/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:trials <https://onco.cc/trials/preopanc/> ;
  onco:people <https://onco.cc/people/marc-besselink/> ;
  onco:journals <https://onco.cc/journals/jco/> .
